Windlas Biotech announces a buyback of 4.7 million shares at ₹1000 each, totaling approximately ₹47 crore. Notably, this buyback excludes shares held by promoters and the record date is set for April 24, 2026.

Windlas Biotech's board has approved a share buyback priced at ₹1,000 per share, suggesting the possibility of returning capital to its shareholders through a tender offer.

Windlas Biotech is planning a potential share buyback, with the board set to discuss it on April 17, 2026. Investors should note that trading activity will be suspended for 48 hours following the release of FY26 results due to SEBI insider trading regulations.